Lululemon Athletica Inc vs Medtronic PLC — how do they compare? Lululemon Athletica Inc trades at $115.82 (market cap $13.25B), while Medtronic PLC trades at $82.41 (market cap $106.61B). The key difference: Medtronic PLC is far larger — about 8× Lululemon Athletica Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Lululemon Athletica Inc pays none. Which is the better fit depends on your goals.
| LULU | MDT | |
|---|---|---|
Market Cap | $13.25B | $106.61B |
Sector | Consumer Cyclical | Health |
52-Week High | $224.03 | $105.35 |
52-Week Low | $105.43 | $73.75 |
Enterprise Value | $13.87B | $125.36B |
Dividend Yield | — | 3.46% |
Signals from Pluang's Aura AI — not financial advice
Lululemon trades at $116.79, up 0.4% on the day, with a bearish technical signal but strong fundamentals including a 13.03% net margin and 32.03% ROE. Recent earnings beats and a $30M investment in nylon recycling startup Syntetica highlight growth initiatives, though the stock faces headwinds from North American weakness and a class-action lawsuit over tariff costs. The current price sits near pivot point resistance at $117.
The outlook is mixed: valuation metrics like a 9.42 P/E suggest potential upside to the $129.29 consensus target, but bearish technicals and competitive pressures pose risks. Investment opportunity lies in robust cash flow and buyback potential, while key risks include brand controversies and macroeconomic sensitivity.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →